KRAS and cancer: Nevertheless, many studies have reported that disrupting these molecular mechanisms blocks the growth of human cancer cells that are K-Ras–dependent but not K-Ras–independent in vitro and in vivo, suggesting that targeting these mechanisms is a valid approach for developing anti–K-Ras therapies.